Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell ImmunotherapyJi Young Yoo, Balveen Kaur, Alena Cristina Jaime‐Ramirez et al.|Clinical Cancer Research|2016Cited by 88
Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966Tae Jin Lee, Ji Young Yoo, W. Shawn Carbonell et al.|Molecular Cancer Therapeutics|2019Cited by 33
Supplementary Figure Legend from Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell ImmunotherapyJi Young Yoo, Balveen Kaur, Alena Cristina Jaime‐Ramirez et al.|Unknown|2023Cited by 0
Supplementary Figures from Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell ImmunotherapyJi Young Yoo, Balveen Kaur, Alena Cristina Jaime‐Ramirez et al.|Unknown|2023Cited by 0
Supplementary Figures from Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell ImmunotherapyJi Young Yoo, Balveen Kaur, Alena Cristina Jaime‐Ramirez et al.|Unknown|2023Cited by 0